Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective

Published:2017-06-12 Issue:7 Volume:17 Page:737-749
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Chung Sun Ju¹,Asgharnejad Mahnaz²,Bauer Lars³,Benitez Arturo⁴,Boroojerdi Babak³,Heidbrede Tanja³,Little Allison⁵,Kim Han Joon⁶

Affiliation:

1. Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

2. UCB Pharma, Raleigh, NC, USA

3. UCB Pharma, Monheim am Rhein, Germany

4. UCB Pharma, São Paulo, Brazil

5. UCB Pharma, Atlanta, GA, USA

6. Seoul National University Hospital, Seoul, South Korea

Funder

UCB Pharma, Smyrna, GA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2017.1336087

Reference70 articles.

1. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

2. Pharmacological Treatment of Parkinson Disease

3. The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

4. Perspectives on recent advances in the understanding and treatment of Parkinson’s disease

5. Continuous dopamine-receptor stimulation in early Parkinson's disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current updates in Restless Legs Syndrome: A pragmatic review;Annals of Movement Disorders;2024-05

2. Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT;Frontiers in Psychiatry;2023-09-27

3. Medication Management in Parkinson’s Disease;Beyond Evidence-Based Medicine;2023

4. Rotigotine for Treating Parkinson’s Disease;NeuroPsychopharmacotherapy;2022

5. The severity progression of non-motor symptoms in Parkinson’s disease: a 6-year longitudinal study in Taiwanese patients;Scientific Reports;2021-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3